Skip to main content
. 2017 Mar 6;13(2):155–161. doi: 10.3988/jcn.2017.13.2.155

Table 2. Response to treatment.

Case Before RTX After RTX Courses of RTX (number)
Patient no. 1 4
 Recurrence (number/months) 3/9 0/9
 Dural thickness (mm) 7.48 2.44
Patient no. 2 8
 Recurrence (number/months) 3/13 0/23
 Dural thickness (mm) 4.93 3.48
Patient no. 3 4
 Recurrence (number/months) 4/11 0/12
 Dural thickness (mm) 9.01 3.96

RTX: rituximab.